Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:


Subscribers log in here


Distal esophageal spasm, nutcracker esophagus, and hypertensive lower esophageal sphincter

INTRODUCTION

The clinical relevance of esophageal motility abnormalities such as distal esophageal spasm (DES) and nutcracker esophagus is best understood when working from a classification system for these abnormalities.

An esophageal motility disorder is defined as motility that differs significantly from accepted normal variations. Classifications of esophageal motility abnormalities are based upon motility findings that exceed two standard deviations from those found in a large group of normal subjects [1].

There is considerable controversy concerning the clinical relevance of abnormal esophageal motility patterns. The most important questions are whether they represent actual disorders or are only manometric abnormalities and whether they cause or explain the patient's symptoms. With the exceptions of achalasia and scleroderma, no specific pathology or pathophysiology has been described for any of these dysmotility patterns, including the more generally accepted "disorder" of DES.

This topic review will attempt to characterize the relevant information on these motility abnormalities without the implication that they are actual disease entities, excluding the one true motility disorder, achalasia. Achalasia and chest pain of esophageal origin are discussed separately. (See "Clinical manifestations and diagnosis of achalasia" and "Pathophysiology and etiology of achalasia" and "Overview of the treatment of achalasia" and "Chest pain of esophageal origin".)

CLASSIFICATION OF ESOPHAGEAL MOTILITY ABNORMALITIES

Esophageal motility abnormalities are generally classified into those that are an isolated phenomenon (primary) (table 1) and those associated with generalized disease (secondary) (table 2). Within each of these major categories, the motility abnormalities can usually be subcategorized into hypercontracting, hypocontracting, and discoordinated motility.

             

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Oct 2014. | This topic last updated: Jul 24, 2014.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. Richter JE, Wu WC, Johns DN, et al. Esophageal manometry in 95 healthy adult volunteers. Variability of pressures with age and frequency of "abnormal" contractions. Dig Dis Sci 1987; 32:583.
  2. Kahrilas PJ. Esophageal motor disorders in terms of high-resolution esophageal pressure topography: what has changed? Am J Gastroenterol 2010; 105:981.
  3. Pandolfino JE, Ghosh SK, Rice J, et al. Classifying esophageal motility by pressure topography characteristics: a study of 400 patients and 75 controls. Am J Gastroenterol 2008; 103:27.
  4. Kahrilas PJ, Ghosh SK, Pandolfino JE. Esophageal motility disorders in terms of pressure topography: the Chicago Classification. J Clin Gastroenterol 2008; 42:627.
  5. Konturek JW, Gillessen A, Domschke W. Diffuse esophageal spasm: a malfunction that involves nitric oxide? Scand J Gastroenterol 1995; 30:1041.
  6. Orlando RC, Bozymski EM. Clinical and manometric effects of nitroglycerin in diffuse esophageal spasm. N Engl J Med 1973; 289:23.
  7. Swamy N. Esophageal spasm: clinical and manometric response to nitroglycerine and long acting nitrites. Gastroenterology 1977; 72:23.
  8. CREAMER B, DONOGHUE E, CODE CF. Pattern of esophageal motility in diffuse spasm. Gastroenterology 1958; 34:782.
  9. Richter JE, Castell DO. Diffuse esophageal spasm: a reappraisal. Ann Intern Med 1984; 100:242.
  10. Dalton CB, Castell DO, Hewson EG, et al. Diffuse esophageal spasm. A rare motility disorder not characterized by high-amplitude contractions. Dig Dis Sci 1991; 36:1025.
  11. Sperandio M, Tutuian R, Gideon RM, et al. Diffuse esophageal spasm: not diffuse but distal esophageal spasm (DES). Dig Dis Sci 2003; 48:1380.
  12. Allen ML, DiMarino AJ Jr. Manometric diagnosis of diffuse esophageal spasm. Dig Dis Sci 1996; 41:1346.
  13. Tutuian R, Mainie I, Agrawal A, et al. Symptom and function heterogenicity among patients with distal esophageal spasm: studies using combined impedance-manometry. Am J Gastroenterol 2006; 101:464.
  14. DiMarino AJ Jr. Characteristics of lower esophageal sphincter function in symptomatic diffuse esophageal spasm. Gastroenterology 1974; 66:1.
  15. Miller LS, Parkman HP, Schiano TD, et al. Treatment of symptomatic nonachalasia esophageal motor disorders with botulinum toxin injection at the lower esophageal sphincter. Dig Dis Sci 1996; 41:2025.
  16. Campo S, Traube M. Lower esophageal sphincter dysfunction in diffuse esophageal spasm. Am J Gastroenterol 1989; 84:928.
  17. Agrawal A, Hila A, Tutuian R, et al. Clinical relevance of the nutcracker esophagus: suggested revision of criteria for diagnosis. J Clin Gastroenterol 2006; 40:504.
  18. Eypasch EP, Stein HJ, DeMeester TR, et al. A new technique to define and clarify esophageal motor disorders. Am J Surg 1990; 159:144.
  19. Jung HY, Puckett JL, Bhalla V, et al. Asynchrony between the circular and the longitudinal muscle contraction in patients with nutcracker esophagus. Gastroenterology 2005; 128:1179.
  20. Korsapati H, Bhargava V, Mittal RK. Reversal of asynchrony between circular and longitudinal muscle contraction in nutcracker esophagus by atropine. Gastroenterology 2008; 135:796.
  21. Katz PO, Dalton CB, Richter JE, et al. Esophageal testing of patients with noncardiac chest pain or dysphagia. Results of three years' experience with 1161 patients. Ann Intern Med 1987; 106:593.
  22. Mujica VR, Mudipalli RS, Rao SS. Pathophysiology of chest pain in patients with nutcracker esophagus. Am J Gastroenterol 2001; 96:1371.
  23. Freidin N, Traube M, Mittal RK, McCallum RW. The hypertensive lower esophageal sphincter. Manometric and clinical aspects. Dig Dis Sci 1989; 34:1063.
  24. Waterman DC, Dalton CB, Ott DJ, et al. Hypertensive lower esophageal sphincter: what does it mean? J Clin Gastroenterol 1989; 11:139.
  25. Cattau EL Jr, Castell DO, Johnson DA, et al. Diltiazem therapy for symptoms associated with nutcracker esophagus. Am J Gastroenterol 1991; 86:272.
  26. Drenth JP, Bos LP, Engels LG. Efficacy of diltiazem in the treatment of diffuse oesophageal spasm. Aliment Pharmacol Ther 1990; 4:411.
  27. Clouse RE, Lustman PJ, Eckert TC, et al. Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities. A double-blind, placebo-controlled trial. Gastroenterology 1987; 92:1027.
  28. Cannon RO 3rd, Quyyumi AA, Mincemoyer R, et al. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med 1994; 330:1411.
  29. Storr M, Allescher HD, Rösch T, et al. Treatment of symptomatic diffuse esophageal spasm by endoscopic injections of botulinum toxin: a prospective study with long-term follow-up. Gastrointest Endosc 2001; 54:754.
  30. Miller LS, Pullela SV, Parkman HP, et al. Treatment of chest pain in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastroesophageal junction. Am J Gastroenterol 2002; 97:1640.
  31. Vanuytsel T, Bisschops R, Farré R, et al. Botulinum toxin reduces Dysphagia in patients with nonachalasia primary esophageal motility disorders. Clin Gastroenterol Hepatol 2013; 11:1115.
  32. Eherer AJ, Schwetz I, Hammer HF, et al. Effect of sildenafil on oesophageal motor function in healthy subjects and patients with oesophageal motor disorders. Gut 2002; 50:758.
  33. Agrawal A, Tutuian R, Hila A, Castell DO. Successful use of phosphodiesterase type 5 inhibitors to control symptomatic esophageal hypercontractility: a case report. Dig Dis Sci 2005; 50:2059.
  34. Agrawal A, Hila A, Tutuian R, et al. Bethanechol improves smooth muscle function in patients with severe ineffective esophageal motility. J Clin Gastroenterol 2007; 41:366.
  35. Khashab MA, Saxena P, Kumbhari V, et al. Peroral endoscopic myotomy as a platform for the treatment of spastic esophageal disorders refractory to medical therapy (with video). Gastrointest Endosc 2014; 79:136.
  36. Stein HJ, DeMeester TR. Therapy of noncardiac chest pain: is there a role for surgery? Am J Med 1992; 92:122S.
  37. Triadafilopoulos G, Tsang HP, Segall GM. Hot water swallows improve symptoms and accelerate esophageal clearance in esophageal motility disorders. J Clin Gastroenterol 1998; 26:239.
  38. Pimentel M, Bonorris GG, Chow EJ, Lin HC. Peppermint oil improves the manometric findings in diffuse esophageal spasm. J Clin Gastroenterol 2001; 33:27.
  39. Spencer HL, Smith L, Riley SA. A questionnaire study to assess long-term outcome in patients with abnormal esophageal manometry. Dysphagia 2006; 21:149.
  40. Song CW, Lee SJ, Jeen YT, et al. Inconsistent association of esophageal symptoms, psychometric abnormalities and dysmotility. Am J Gastroenterol 2001; 96:2312.
  41. Khatami SS, Khandwala F, Shay SS, Vaezi MF. Does diffuse esophageal spasm progress to achalasia? A prospective cohort study. Dig Dis Sci 2005; 50:1605.
  42. Dalton CB, Castell DO, Richter JE. The changing faces of the nutcracker esophagus. Am J Gastroenterol 1988; 83:623.